|
Targeted Therapies for Cancers Containing NRG1 Fusions
Researchers at TGen, in collaboration with the Mayo Clinic, have identified a new method of targeted cancer treatment by selecting a patient population based on the presence of Neuregulin-1 (NRG1) somatic gene fusion events (i.e., NRG1 fusions). Tumors of the patients in this identified population may be treated with targeted therapies, including Epidermal...
Published: 5/8/2025
|
Inventor(s): John Carpten, David Craig, Sara Byron, Jessica Aldrich, Keith Stewart, Mitesh Borad, George Vasmatzis, Michael Barrett, Alan Bryce
Keywords(s):
Category(s): Therapeutics
|
